Colon News and Research

RSS

Researchers achieve 80% reduction in liver metastasis by restricting growth of blood vessels

The International Journal of Cancer has just published the results of an experimental therapy tested on mice. The research, led by the Signaling Lab research group of the UPV/EHU's Faculty of Medicine and Pharmacy and the Department of Pharmacology, Pharmacy and Pharmaceutical Technology of the University of Santiago de Compostela, achieved an 80% reduction in liver metastasis brought about by colon cancer.

14 Mar 2018

Routine screenings and early detection can help protect from colorectal cancer

Having a colonoscopy to screen for colorectal cancer is not on anyone's list of favorite activities. However, with colorectal cancer ranking as the second leading cause of cancer death in the United States, undergoing the outpatient procedure as per the Centers for Disease Control's (CDC) guidelines may be one of the smartest things you can do for your overall health.

9 Mar 2018

Scientists develop first-of-its-kind collagen-based membrane for use in microchips

In a step toward better diagnosis and treatment of digestive conditions, such as inflammatory bowel disease, scientists report in ACS Biomaterials & Engineering that they have developed a first-of-its-kind collagen-based membrane for use in microchips.

7 Mar 2018

Johns Hopkins researchers invent new class of immunotherapy drugs to fight cancer

Johns Hopkins researchers have invented a new class of cancer immunotherapy drugs that are more effective at harnessing the power of the immune system to fight cancer.

2 Mar 2018

Myriad Genetics shows strong commitment, support in the fight against colorectal cancer

Myriad Genetics, Inc., a leader in molecular diagnostics and personalized medicine, continues to demonstrate an unmatched commitment to hereditary cancer risk assessment and genetic testing during National Colorectal Cancer Awareness Month.

2 Mar 2018

Nut consumption linked to colon cancer survival

People with stage III colon cancer who regularly eat nuts are at significantly lower risk of cancer recurrence and mortality than those who don't, according to a new, large study led by researchers at Yale Cancer Center.

1 Mar 2018

Combined analysis makes risk prediction for colorectal cancer more precise

If first-degree relatives are affected by colorectal cancer, this indicates a person's own elevated risk of developing bowel cancer. The same holds true for people who have large numbers of genetic risk markers in their genome.

26 Feb 2018

Wine polyphenols may be good for oral health

Sipping wine is good for your colon and heart, possibly because of the beverage's abundant and structurally diverse polyphenols. Now researchers report in ACS' Journal of Agricultural and Food Chemistry that wine polyphenols might also be good for your oral health.

21 Feb 2018

Some genes can drive both metastasis and initial stages of tumor growth

In spite of the difference between the cell functions responsible for giving rise to a tumor and for the metastasis of this same tumor, studies at IRB Barcelona using the fly Drosophila melanogaster reveal that some genes can drive both phenomena.

21 Feb 2018

Stanford researchers explore how gut bacteria respond to common changes in habitat

Researchers at Stanford University are studying how bacteria living in the gut respond to common changes within their habitat, working with mice.

20 Feb 2018

'Click chemistry' approach may improve disease-fighting properties of drugs

Researchers at The Scripps Research Institute have developed a quick and easy way to simultaneously modify dozens of drugs or molecules to improve their disease-fighting properties.

19 Feb 2018

Scientists develop fluorescent probe to identify cancer stem cells

Cells with stem-cell characteristics appear to be especially important in the formation and metastasis of tumors. Scientists have now developed a universal fluorescent probe for these “cancer stem cells”. As reported in the journal Angewandte Chemie, this dye also selectively kills off the cells.

19 Feb 2018

FDA approves first treatment to reduce risk of NSCLC progression

The U.S. Food and Drug Administration today approved Imfinzi (durvalumab) for the treatment of patients with stage III non-small cell lung cancer (NSCLC) whose tumors are not able to be surgically removed (unresectable) and whose cancer has not progressed after treatment with chemotherapy and radiation (chemoradiation).

18 Feb 2018

Postoperative pain control following extensive pelvic exenteration

In the March issue of Diseases of the Colon & Rectum, surgeons from Australia discuss postoperative pain control following one of the most extensive operations performed for pelvic cancer.

13 Feb 2018

Patients with Huntington's have lesser cancer than general population

Patients with Huntington's disease, a fatal genetic illness that causes the breakdown of nerve cells in the brain, have up to 80 percent less cancer than the general population.

12 Feb 2018

Myriad’s myRisk Hereditary Cancer test finds inherited gene mutations in more than 12% of prostate cancer patients

Myriad Genetics, Inc., a leader in molecular diagnostics and personalized medicine, announced today that results from a large 1,162 patient study of the Myriad myRisk Hereditary Cancer test will be featured during the poster presentation at the 2018 Genitourinary Cancer Symposium in San Francisco, Calif.

8 Feb 2018

New tool to monitor patterns and trends of cancer burden across Europe

On the occasion of the World Cancer Day, the European Commission's Joint Research Centre launched the European Cancer Information System (ECIS), which makes it possible to explore geographical patterns and temporal trends of cancer incidence, mortality, and survival from data submitted by some 150 European population-based cancer registries.

6 Feb 2018

Researchers use innovative method to screen kinases for cancer drug's effectiveness

In recent years, a powerful suite of drugs known as kinase inhibitors have been developed to treat cancer and other diseases. Primary targets of such drugs include a family of receptor tyrosine kinases (RTKs) which protrude from cell surfaces like antennae and can activate cancer-related pathways in virtually all types of cancer when signaling molecules bind with them.

5 Feb 2018

RCSI to lead major study for finding new ways to treat colorectal cancer patients

RCSI is leading an international team of scientists on a major research study “COLOSSUS” which aims to provide new and more effective ways to classify and treat patients with colorectal cancer.

2 Feb 2018

New modular platform offers robust biological approach that targets endless number of diseases

The biological complexity of cancer and other diseases demands a more formidable arsenal of therapies than currently available. Most therapeutic approaches ignore the dynamic molecular network of genes, targeting instead only very few selected disease-related genes.

1 Feb 2018